The influence of vitamin d, vitamin k, and parathyroid hormone on anemia severity in chronic kidney disease patients undergoing hemodialysis

Read full text
Authors: Shahad Luay Abdulkareem Al-abdali, Raid J. M. Al-timimi, Ali Ghafil Al Zaydi, Arif Sami Malik
Cited by: 0

Abstract

Patients undergoing hemodialysis for end-stage renal disease (ESRD) frequently have anemia.Disruptions in vitamin D and vitamin K metabolism, along with alterations in parathyroid hormone levels, may influence the severity of anemia in this population.This study investigated the impact of vitamin D, vitamin K, and parathyroid hormone (PTH) levels on the severity of patients with ESRD undergoing maintenance hemodialysis.The Hamida Al-Masfah Dialysis Centre at Al-Imamain Al-Kadhimain Teaching Hospital in Baghdad conducted a prospective cross-sectional study from November 1, 2023, to April 20, 2024.One hundred standard hemodialysis patients aged 18 years or older were recruited.Patients were classified based on anemia severity (Hb

Fields of Study & Subjects

Parathyroid Disorders and Treatments Dialysis and Renal Disease Management Erythropoietin and Anemia Treatment

Publication details

Journal / source
ACTA Pharmaceutica Sciencia
Volume
64
Issue
1
Pages
79–79
Publication date
1 January 2026
Language
EN